ArticleClinical cancer research : an official journal of the American Association for Cancer Research2025

FDA Approval Summary: Vorasidenib for IDH-Mutant Grade 2 Astrocytoma or Oligodendroglioma Following Surgery.

Michael I Barbato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.